Overview
Lincoln Nadauld is an Oncologist in Layton, Utah. Dr. Nadauld is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Neuroendocrine Tumor, Pleuropulmonary Blastoma, Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Bone Marrow Aspiration. Dr. Nadauld is currently accepting new patients.
His clinical research consists of co-authoring 57 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 W Layton Pkwy, Layton, UT 84041
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Utah Adult Services
Glynn Gilcrease is an Oncologist and a Hematologist in Salt Lake City, Utah. Dr. Gilcrease is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Liver Embolization, and Endoscopy. Dr. Gilcrease is currently accepting new patients.
University Of Utah Adult Services
Ignacio Garrido-Laguna is an Oncologist and a Hematologist in Salt Lake City, Utah. Dr. Garrido-Laguna is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatoblastoma, and Pancreatectomy. Dr. Garrido-Laguna is currently accepting new patients.
Ihc Health Services Inc
Ramya Thota is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Thota is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Stomach Cancer, Cholangiocarcinoma (Bile Duct Cancer), Febrile Neutropenia, Colorectal Cancer, and Nerve Decompression. Dr. Thota is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Neuroendocrine TumorDr. Nadauld isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colorectal CancerDr. Nadauld isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Nadauld isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Nadauld isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Nadauld isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Nadauld isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Appendix CancerDr. Nadauld isExperienced. Learn about Appendix Cancer.
- Bladder CancerDr. Nadauld isExperienced. Learn about Bladder Cancer.
- Bone Marrow AspirationDr. Nadauld isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Nadauld isExperienced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Nadauld isExperienced. Learn about Chromophobe Renal Cell Carcinoma.